A Clinical Study of the Effects of Environmental Pollution on Obesity
1 other identifier
observational
800
1 country
3
Brief Summary
This study aims to assess the effects of environmental pollution (including environmental indicators such as PM2.5, PM5, PM10, SO2, NOX, O3, and greening index) on obese patients and to explore the possible mechanisms by which environmental pollution promotes obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2011
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2024
CompletedFirst Submitted
Initial submission to the registry
October 31, 2024
CompletedFirst Posted
Study publicly available on registry
November 1, 2024
CompletedNovember 1, 2024
October 1, 2024
13.8 years
October 31, 2024
October 31, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
incidence of obesity
the time for overweight to obesity
From 18 years old until the developing obesity, through study completion, an average of 5 year.
Study Arms (1)
the obesity group
Obese patients attending the First Affiliated Hospital of Chongqing Medical University, the Affiliated Hospital of Yunnan University, and the Second People's Hospital of Qujing City.
Interventions
Eligibility Criteria
This is a retrospective observational study, which is expected to include patients diagnosed with obesity ( body mass index (BMI) ≥ 28 kg/m2).
You may qualify if:
- Age ≥18 years;
- obese patients with BMI ≥30;
- patients without surgical treatment prior to enrolment;
- willingness to participate in the study and sign an informed consent form;
- complete clinical data.
You may not qualify if:
- patients with systemic diseases such as severe cardiorespiratory insufficiency affecting the choice of treatment regimen;
- patients assessed by the investigator to be inappropriate for enrolment;
- patients with incomplete clinical data.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dong Penglead
- Affiliated Hospital of Yunnan Universitycollaborator
- The Second People's Hospital of Qujingcollaborator
Study Sites (3)
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400016, China
Affiliated Hospital of Yunnan University
Kunming, Yunnan, 650000, China
The Second People's Hospital of Qujing
Kunming, Yunnan, 650000, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 31, 2024
First Posted
November 1, 2024
Study Start
January 1, 2011
Primary Completion
October 30, 2024
Study Completion
October 30, 2024
Last Updated
November 1, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share
Ethics committees of the clinical centres where the studies were conducted did not allow the release of patient data.